Key facts
- Decode Age’s last known valuation is $8.3M (Feb 2024).
- It has raised $2.3M; the latest was Early Stage VC ($1.6M) in Dec 2025.
- Notable investors include Anupam Mittal, Foundation for Science Innovation and Development, IVY Growth Associates, Krishna Chigurupati, Lord's Mark Industries — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Decode Age
- ·The full record, as it builds
Funding rounds
No funding rounds for Decode Age are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Decode Age
Operator of a research company intended to help increase human healthspan. The company utilizes scientific advancements to get to the root cause of chronic diseases and slow down the aging process, enabling customers to get access to science-based preventive longevity predictive biological age tests to improve their healthspan.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2021
- Employees
- 50
- Website
- decodeage.com/
- Ownership
- Privately Held (backing)
Decode Age doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Decode Age shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Decode Age in its N-PORT filings yet. We sweep new filings monthly.